Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

NGI-1

Catalog No. T7366Cas No. 790702-57-7
Alias ML414

NGI-1 (ML414) is a cell-permeable inhibitor of oligosaccharyltransferase (OST) that can effectively reduce virus infectivity without affecting cell viability.

NGI-1

NGI-1

Catalog No. T7366Alias ML414Cas No. 790702-57-7
NGI-1 (ML414) is a cell-permeable inhibitor of oligosaccharyltransferase (OST) that can effectively reduce virus infectivity without affecting cell viability.
Pack SizePriceAvailabilityQuantity
2 mg$36In Stock
5 mg$57In Stock
10 mg$93In Stock
25 mg$156In Stock
50 mg$233In Stock
100 mg$346In Stock
1 mL x 10 mM (in DMSO)$63In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "NGI-1"

Select Batch
Purity:≥95%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
NGI-1 (ML414) is a cell-permeable inhibitor of oligosaccharyltransferase (OST) that can effectively reduce virus infectivity without affecting cell viability.
In vitro
In non-small-cell lung cancer cells, NGI-1 blocks cell-surface localization and signaling of the epidermal growth factor receptor (EGFR) glycoprotein, but selectively arrests proliferation in only those cell lines that are dependent on EGFR (or fibroblast growth factor, FGFR) for survival[1].
AliasML414
Chemical Properties
Molecular Weight394.51
FormulaC17H22N4O3S2
Cas No.790702-57-7
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 160 mg/mL (405.57 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5348 mL12.6739 mL25.3479 mL126.7395 mL
5 mM0.5070 mL2.5348 mL5.0696 mL25.3479 mL
10 mM0.2535 mL1.2674 mL2.5348 mL12.6739 mL
20 mM0.1267 mL0.6337 mL1.2674 mL6.3370 mL
50 mM0.0507 mL0.2535 mL0.5070 mL2.5348 mL
100 mM0.0253 mL0.1267 mL0.2535 mL1.2674 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NGI-1 | purchase NGI-1 | NGI-1 cost | order NGI-1 | NGI-1 chemical structure | NGI-1 in vitro | NGI-1 formula | NGI-1 molecular weight